NovelStem International Corp. (NSTM)
USD 0.01
(0.0%)
USD 0.01
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 2.25 Million USD | -1.38% |
| 2022 | 2.28 Million USD | -12.38% |
| 2021 | 2.6 Million USD | -26.66% |
| 2020 | 3.55 Million USD | 0.0% |
| 2013 | 31.47 Million USD | 18.24% |
| 2012 | 26.61 Million USD | 46.06% |
| 2011 | 18.22 Million USD | -61.49% |
| 2010 | 47.31 Million USD | -17.86% |
| 2009 | 57.6 Million USD | -13.94% |
| 2008 | 66.93 Million USD | -28.77% |
| 2007 | 93.97 Million USD | -6.03% |
| 2006 | 100 Million USD | 20.06% |
| 2005 | 83.3 Million USD | 19.33% |
| 2004 | 69.81 Million USD | 22.73% |
| 2003 | 56.88 Million USD | -8.36% |
| 2002 | 62.06 Million USD | -56.71% |
| 2001 | 143.37 Million USD | -15.3% |
| 2000 | 169.27 Million USD | 170.84% |
| 1999 | 62.5 Million USD | 626.74% |
| 1998 | 8.6 Million USD | -31.75% |
| 1997 | 12.6 Million USD | 53.66% |
| 1996 | 8.2 Million USD | 41.38% |
| 1995 | 5.8 Million USD | -30.12% |
| 1994 | 8.3 Million USD | -18.63% |
| 1993 | 10.2 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 2.33 Million USD | -2.59% |
| 2024 Q1 | 2.4 Million USD | 6.49% |
| 2023 Q1 | 2.2 Million USD | -3.65% |
| 2023 FY | 2.25 Million USD | -1.38% |
| 2023 Q4 | 2.25 Million USD | 11.67% |
| 2023 Q3 | 2.01 Million USD | -3.98% |
| 2023 Q2 | 2.1 Million USD | -4.55% |
| 2022 Q3 | 2.03 Million USD | -5.94% |
| 2022 Q4 | 2.28 Million USD | 12.55% |
| 2022 FY | 2.28 Million USD | -12.38% |
| 2022 Q1 | 3.6 Million USD | 38.14% |
| 2022 Q2 | 2.15 Million USD | -40.08% |
| 2021 Q1 | - USD | 0.0% |
| 2021 FY | 2.6 Million USD | -26.66% |
| 2021 Q4 | 2.6 Million USD | 0.0% |
| 2020 FY | 3.55 Million USD | 0.0% |
| 2013 Q3 | 33.7 Million USD | 31.68% |
| 2013 FY | 31.47 Million USD | 18.24% |
| 2013 Q1 | 25.44 Million USD | -4.42% |
| 2013 Q2 | 25.59 Million USD | 0.62% |
| 2013 Q4 | 31.47 Million USD | -6.64% |
| 2012 Q2 | 16.32 Million USD | -7.47% |
| 2012 Q3 | 14.73 Million USD | -9.76% |
| 2012 Q4 | 26.61 Million USD | 80.68% |
| 2012 FY | 26.61 Million USD | 46.06% |
| 2012 Q1 | 17.64 Million USD | -3.19% |
| 2011 Q3 | 18.89 Million USD | -24.28% |
| 2011 FY | 18.22 Million USD | -61.49% |
| 2011 Q1 | 24.92 Million USD | -47.32% |
| 2011 Q4 | 18.22 Million USD | -3.58% |
| 2011 Q2 | 24.95 Million USD | 0.13% |
| 2010 Q2 | 53.38 Million USD | -12.3% |
| 2010 Q4 | 47.31 Million USD | -12.97% |
| 2010 Q3 | 54.37 Million USD | 1.86% |
| 2010 Q1 | 60.86 Million USD | 5.66% |
| 2010 FY | 47.31 Million USD | -17.86% |
| 2009 Q4 | 57.6 Million USD | 5.13% |
| 2009 Q1 | 67.45 Million USD | 0.76% |
| 2009 FY | 57.6 Million USD | -13.94% |
| 2009 Q2 | 54.17 Million USD | -19.69% |
| 2009 Q3 | 54.79 Million USD | 1.15% |
| 2008 Q1 | 93.01 Million USD | -1.02% |
| 2008 FY | 66.93 Million USD | -28.77% |
| 2008 Q3 | 77.23 Million USD | -7.93% |
| 2008 Q2 | 83.89 Million USD | -9.81% |
| 2008 Q4 | 66.93 Million USD | -13.33% |
| 2007 Q1 | 104.18 Million USD | 4.18% |
| 2007 FY | 93.97 Million USD | -6.03% |
| 2007 Q4 | 93.97 Million USD | -7.59% |
| 2007 Q3 | 101.7 Million USD | 12.85% |
| 2007 Q2 | 90.12 Million USD | -13.5% |
| 2006 Q2 | 84.51 Million USD | -5.02% |
| 2006 Q4 | 100 Million USD | -0.1% |
| 2006 FY | 100 Million USD | 20.06% |
| 2006 Q3 | 100.1 Million USD | 18.45% |
| 2006 Q1 | 88.98 Million USD | 6.82% |
| 2005 Q4 | 83.3 Million USD | 17.48% |
| 2005 Q3 | 70.9 Million USD | -0.67% |
| 2005 Q2 | 71.38 Million USD | -1.82% |
| 2005 Q1 | 72.7 Million USD | 4.15% |
| 2005 FY | 83.3 Million USD | 19.33% |
| 2004 Q4 | 69.81 Million USD | 4.67% |
| 2004 FY | 69.81 Million USD | 22.73% |
| 2004 Q1 | 70.81 Million USD | 24.49% |
| 2004 Q2 | 66.8 Million USD | -5.66% |
| 2004 Q3 | 66.69 Million USD | -0.15% |
| 2003 Q2 | 59.05 Million USD | -3.21% |
| 2003 Q1 | 61 Million USD | -1.71% |
| 2003 FY | 56.88 Million USD | -8.36% |
| 2003 Q3 | 58.36 Million USD | -1.17% |
| 2003 Q4 | 56.88 Million USD | -2.54% |
| 2002 FY | 62.06 Million USD | -56.71% |
| 2002 Q3 | 63.61 Million USD | -53.84% |
| 2002 Q4 | 62.06 Million USD | -2.43% |
| 2002 Q2 | 137.81 Million USD | -3.5% |
| 2002 Q1 | 142.8 Million USD | -0.39% |
| 2001 Q1 | 161.78 Million USD | -4.43% |
| 2001 FY | 143.37 Million USD | -15.3% |
| 2001 Q2 | 165.14 Million USD | 2.08% |
| 2001 Q4 | 143.37 Million USD | -9.75% |
| 2001 Q3 | 158.86 Million USD | -3.8% |
| 2000 Q3 | 188.62 Million USD | -1.86% |
| 2000 Q4 | 169.27 Million USD | -10.26% |
| 2000 Q2 | 192.18 Million USD | -3.56% |
| 2000 Q1 | 199.27 Million USD | 218.84% |
| 2000 FY | 169.27 Million USD | 170.84% |
| 1999 Q4 | 62.5 Million USD | -5.45% |
| 1999 Q3 | 66.1 Million USD | 13.97% |
| 1999 FY | 62.5 Million USD | 626.74% |
| 1999 Q1 | 8.8 Million USD | 2.33% |
| 1999 Q2 | 58 Million USD | 559.09% |
| 1998 Q2 | 11.1 Million USD | -8.26% |
| 1998 Q3 | 11.4 Million USD | 2.7% |
| 1998 Q4 | 8.6 Million USD | -24.56% |
| 1998 Q1 | 12.1 Million USD | -3.97% |
| 1998 FY | 8.6 Million USD | -31.75% |
| 1997 Q3 | 8.7 Million USD | 3.57% |
| 1997 FY | 12.6 Million USD | 53.66% |
| 1997 Q4 | 12.6 Million USD | 44.83% |
| 1997 Q1 | 6.8 Million USD | -17.07% |
| 1997 Q2 | 8.4 Million USD | 23.53% |
| 1996 Q4 | 8.2 Million USD | 9.33% |
| 1996 FY | 8.2 Million USD | 41.38% |
| 1996 Q1 | 6.5 Million USD | 12.07% |
| 1996 Q2 | 9.4 Million USD | 44.62% |
| 1996 Q3 | 7.5 Million USD | -20.21% |
| 1995 FY | 5.8 Million USD | -30.12% |
| 1995 Q3 | 6.6 Million USD | 0.0% |
| 1995 Q4 | 5.8 Million USD | -12.12% |
| 1994 Q4 | 8.3 Million USD | -5.68% |
| 1994 FY | 8.3 Million USD | -18.63% |
| 1994 Q2 | 9.8 Million USD | 0.0% |
| 1994 Q3 | 8.8 Million USD | -10.2% |
| 1993 Q4 | 10.2 Million USD | 0.0% |
| 1993 FY | 10.2 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| American Bio Medica Corporation | 1.26 Million USD | -77.663% |
| Arrayit Corporation | 1 Million USD | -125.367% |
| Atlantic International Corp. | 4.43 Million USD | 49.18% |
| Biocept, Inc. | 30.87 Million USD | 92.697% |
| Bioqual, Inc. | 56.58 Million USD | 96.016% |
| CardioGenics Holdings Inc | 231.93 Thousand USD | -872.072% |
| DermTech, Inc. | 121.93 Million USD | 98.151% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 4.18 Billion USD | 99.946% |
| HTG Molecular Diagnostics, Inc. | 17.77 Million USD | 87.318% |
| iMD Companies, Inc. | 190.13 Thousand USD | -1085.748% |
| IDenta Corp. | 1.52 Million USD | -47.426% |
| Interpace Biosciences, Inc. | 13.02 Million USD | 82.685% |
| Integrative Health Technologies, Inc. | 8.25 Million USD | 72.679% |
| InVitro International | 1.53 Million USD | -46.971% |
| Lumos Diagnostics Holdings Limited | 26.83 Million USD | 91.599% |
| Many Bright Ideas Technologies Inc. | 2312.00 USD | -97414.965% |
| Medical Imaging Corp. | 4.19 Million USD | 46.213% |
| Optigenex Inc. | 1.88 Million USD | -19.396% |
| PharmChem, Inc. | 2.76 Million USD | 18.478% |
| Proteome Sciences plc | 14.58 Million USD | 84.543% |
| Response Genetics, Inc | 48.88 Million USD | 95.388% |
| Rennova Health, Inc. | 20.57 Million USD | 89.041% |
| RushNet, Inc. | 6.04 Million USD | 62.72% |
| ScreenPro Security Inc. | 1.26 Million USD | -78.739% |
| Stella Diagnostics Inc. | 472.42 Thousand USD | -377.23% |
| StageZero Life Sciences Ltd. | 700.65 Thousand USD | -221.778% |
| Todos Medical Ltd. | 15.26 Million USD | 85.233% |